Biotech | May 09, 2022
SCG Cell Therapy announces HSA clinical trial approval of TCR-T cell therapy for liver cancer
SCG101 is an autologous T-cell receptor (TCR) T-cell therapy for liver cancer
SCG101 is an autologous T-cell receptor (TCR) T-cell therapy for liver cancer
Takeda and United Nations Global Compact Network of India (UNGCNI) join hands
Aims to increase compliance and improve outcomes for People with Diabetes (PwD)
He was previously working as the CEO of IVD business at Trivitron Healthcare and drove its growth through innovation
Ahead of International Thalassemia Day on 8th May, medical professionals and representatives of patient bodies participated in a virtual discussion on the current situation of Thalassemia management in India
There is a need for the Ministry of Health to put it on the priority list and address the issues, which are numerous
Digital PCR format allows for rapid turnaround time to facilitate fast and accurate post-transplant treatment decisions
The production suspension impacts commercial and clinical trial supply
Upon closing, the Quakertown business will become an independent company called Microsize
Novel approach driven by GN Corp Japan with potentials in neurological illnesses
Subscribe To Our Newsletter & Stay Updated
